Diseases

Explore disease pages that summarize symptoms, diagnostic context, and related care topics.

Featured: 100

Browse A-Z

Page 6 of 67

Diseases starting with U (6,629)

T43216A

Underdosing of selective serotonin and norepinephrine reuptake inhibitors, initial encounter

T43216S

Underdosing of selective serotonin and norepinephrine reuptake inhibitors, sequela

T43216D

Underdosing of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter

T43226A

Underdosing of selective serotonin reuptake inhibitors, initial encounter

T43226S

Underdosing of selective serotonin reuptake inhibitors, sequela

T43226D

Underdosing of selective serotonin reuptake inhibitors, subsequent encounter

T481X6A

Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter

T481X6S

Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], sequela

T481X6D

Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter

T50B16A

Underdosing of smallpox vaccines, initial encounter

T50B16S

Underdosing of smallpox vaccines, sequela

T50B16D

Underdosing of smallpox vaccines, subsequent encounter

T472X6A

Underdosing of stimulant laxatives, initial encounter

T472X6S

Underdosing of stimulant laxatives, sequela

T472X6D

Underdosing of stimulant laxatives, subsequent encounter

T422X6A

Underdosing of succinimides and oxazolidinediones, initial encounter

T422X6S

Underdosing of succinimides and oxazolidinediones, sequela

T422X6D

Underdosing of succinimides and oxazolidinediones, subsequent encounter

T370X6A

Underdosing of sulfonamides, initial encounter

T370X6S

Underdosing of sulfonamides, sequela

T370X6D

Underdosing of sulfonamides, subsequent encounter

T40726A

Underdosing of synthetic cannabinoids, initial encounter

T40726S

Underdosing of synthetic cannabinoids, sequela

T40726D

Underdosing of synthetic cannabinoids, subsequent encounter

T43026A

Underdosing of tetracyclic antidepressants, initial encounter

T43026S

Underdosing of tetracyclic antidepressants, sequela

T43026D

Underdosing of tetracyclic antidepressants, subsequent encounter

T364X6A

Underdosing of tetracyclines, initial encounter

T364X6S

Underdosing of tetracyclines, sequela

T364X6D

Underdosing of tetracyclines, subsequent encounter

T415X6A

Underdosing of therapeutic gases, initial encounter

T415X6S

Underdosing of therapeutic gases, sequela

T415X6D

Underdosing of therapeutic gases, subsequent encounter

T45616A

Underdosing of thrombolytic drugs, initial encounter

T45616S

Underdosing of thrombolytic drugs, sequela

T45616D

Underdosing of thrombolytic drugs, subsequent encounter

T381X6A

Underdosing of thyroid hormones and substitutes, initial encounter

T381X6S

Underdosing of thyroid hormones and substitutes, sequela

T381X6D

Underdosing of thyroid hormones and substitutes, subsequent encounter

T40426A

Underdosing of tramadol, initial encounter

T40426S

Underdosing of tramadol, sequela

T40426D

Underdosing of tramadol, subsequent encounter

T43016A

Underdosing of tricyclic antidepressants, initial encounter

T43016S

Underdosing of tricyclic antidepressants, sequela

T43016D

Underdosing of tricyclic antidepressants, subsequent encounter

T48906A

Underdosing of unspecified agents primarily acting on the respiratory system, initial encounter

T48906S

Underdosing of unspecified agents primarily acting on the respiratory system, sequela

T48906D

Underdosing of unspecified agents primarily acting on the respiratory system, subsequent encounter

T46906A

Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter

T46906S

Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela

T46906D

Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter

T4796XA

Underdosing of unspecified agents primarily affecting the gastrointestinal system, initial encounter

T4796XS

Underdosing of unspecified agents primarily affecting the gastrointestinal system, sequela

T4796XD

Underdosing of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter

T4146XA

Underdosing of unspecified anesthetics, initial encounter

T4146XS

Underdosing of unspecified anesthetics, sequela

T4146XD

Underdosing of unspecified anesthetics, subsequent encounter

T43206A

Underdosing of unspecified antidepressants, initial encounter

T43206S

Underdosing of unspecified antidepressants, sequela

T43206D

Underdosing of unspecified antidepressants, subsequent encounter

T4276XA

Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter

T4276XS

Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, sequela

T4276XD

Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter

T43506A

Underdosing of unspecified antipsychotics and neuroleptics, initial encounter

T43506S

Underdosing of unspecified antipsychotics and neuroleptics, sequela

T43506D

Underdosing of unspecified antipsychotics and neuroleptics, subsequent encounter

T48206A

Underdosing of unspecified drugs acting on muscles, initial encounter

T48206S

Underdosing of unspecified drugs acting on muscles, sequela

T48206D

Underdosing of unspecified drugs acting on muscles, subsequent encounter

T44906A

Underdosing of unspecified drugs primarily affecting the autonomic nervous system, initial encounter

T44906S

Underdosing of unspecified drugs primarily affecting the autonomic nervous system, sequela

T44906D

Underdosing of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter

T50906A

Underdosing of unspecified drugs, medicaments and biological substances, initial encounter

T50906S

Underdosing of unspecified drugs, medicaments and biological substances, sequela

T50906D

Underdosing of unspecified drugs, medicaments and biological substances, subsequent encounter

T45606A

Underdosing of unspecified fibrinolysis-affecting drugs, initial encounter

T45606S

Underdosing of unspecified fibrinolysis-affecting drugs, sequela

T45606D

Underdosing of unspecified fibrinolysis-affecting drugs, subsequent encounter

T41206A

Underdosing of unspecified general anesthetics, initial encounter

T41206S

Underdosing of unspecified general anesthetics, sequela

T41206D

Underdosing of unspecified general anesthetics, subsequent encounter

T38906A

Underdosing of unspecified hormone antagonists, initial encounter

T38906S

Underdosing of unspecified hormone antagonists, sequela

T38906D

Underdosing of unspecified hormone antagonists, subsequent encounter

T38806A

Underdosing of unspecified hormones and synthetic substitutes, initial encounter

T38806S

Underdosing of unspecified hormones and synthetic substitutes, sequela

T38806D

Underdosing of unspecified hormones and synthetic substitutes, subsequent encounter

T40606A

Underdosing of unspecified narcotics, initial encounter

T40606S

Underdosing of unspecified narcotics, sequela

T40606D

Underdosing of unspecified narcotics, subsequent encounter

T3996XA

Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter

T3996XS

Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela

T3996XD

Underdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter

T4596XA

Underdosing of unspecified primarily systemic and hematological agent, initial encounter

T4596XS

Underdosing of unspecified primarily systemic and hematological agent, sequela

T4596XD

Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter

T40906A

Underdosing of unspecified psychodysleptics [hallucinogens], initial encounter

T40906S

Underdosing of unspecified psychodysleptics [hallucinogens], sequela

T40906D

Underdosing of unspecified psychodysleptics [hallucinogens], subsequent encounter

T43606A

Underdosing of unspecified psychostimulants, initial encounter